Call: 1-800-887-8100

 

New here?
Please register Already a member?
Sign in now

 
Starting COPAXONE(R) Choosing a Therapy Importance of Therapy Therapy Expectations

Share Print

Starting COPAXONE®

Shared Solutions® is your support every step of the way

Even though you may just be starting your journey, we have over a decade of experience assisting thousands of people who have been touched by relapsing-remitting multiple sclerosis (RRMS).

Your Case Manager has it covered

Once you take the next positive step toward therapy and enroll with Shared Solutions®, a Case Manager will be assigned to you. From financial resources, to in-home injection training, 24/7 nurse support, or simply lending an ear, Shared Solutions® provides access to everything you need to help you start—and successfully stay—on treatment. When your Case Manager calls, you can expect to talk about:

Insurance FinancialInsurance benefits investigation and financial assistance
Fast and affordable access to COPAXONE®Injection TrainingInjection assistance
Free in-home training with a nurse and customized materials to help with your daily injections Home Delivery.pngHome delivery
Delivery of COPAXONE® refills right to your door (if you qualify) Peer SupportOne-on-one peer support
Talk to someone who knows what it’s like to live with MS

Call Shared Solutions® at 1-800-887-8100 to get started. We’re here for you Monday through Friday, from 8:00 AM to 8:00 PM (CT). For urgent needs, our MS-certified nurses are available 24/7.

Our experience enhances yours

COPAXONE® is the most prescribed relapsing-remitting MS (RRMS) therapy in the US and has 19 years of clinical experience.1-3 In fact, if you add up the number of years that people with RRMS have taken COPAXONE®, it equals over 1 million patient-years of experience worldwide.2

Current rating: 3.2 (21 ratings)
References:
1. IMS Health National Prescription Audit, August 2010. Data is proprietary to IMS Health. 2. Data on file. Teva Neuroscience, Inc. 3. Ford C, Goodman AD, Johnson K, et al. Mult Scler. 2010;16(3):342-350.
COP100006105/101803
  • COPAXONE® (glatiramer acetate injection) is indicated for the reduction of the frequency of relapses in relapsing-remitting multiple sclerosis, including patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.

Important Safety Information About COPAXONE®

  • The most common side effects of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These reactions are usually mild and seldom require professional treatment. Be sure to tell your doctor about any side effects.

    Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and go away by themselves without further problems.

    A permanent indentation under the skin at the injection site may occur, due to a local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.

    After you inject COPAXONE®, call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, severe pain at the injection site or other uncomfortable changes in your general health. Do not give yourself any more injections until your doctor tells you to begin again.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

#1 Prescribed RRMS therapy in the US*

Suggested articles

Benefits & Insurance Assistance

COPAXONE Co-pay Solutions™

Therapy and Immune Health

10 Tips for CarePartners

Choosing a Therapy

Your MS Online Planner

My recent articles

About Shared Solutions®

Peer Connections

Available Therapies

Portraits of MS
Learn more about COPAXONE®.
Peer ConnectionsSometimes it helps to talk to someone whose MS experience is close to yours.
Visit Peer Connections.
PhyllisDon’t wait until you have another MS attack to start therapy … just decide you’re going to commit to fighting your MS head on!

—Phyllis J., on COPAXONE® for RRMS since 2003
master_PDF.png  Download Adobe Acrobat
*IMS Health National Prescription Audit, May 2011. Data is proprietary to IMS Health.
 

COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd. Shared Solutions® is a registered trademark of Teva Neuroscience, Inc. autoject® 2 for glass syringe is a registered trademark of Owen Mumford, Ltd. COPAXONE CO-PAY SOLUTIONS™ is a trademark of Teva Pharmaceutical Industries Ltd. © 2011, Teva Neuroscience, Inc. All Rights Reserved. This site is intended for US residents only.

The brands listed are the trademarks and registered trademarks of their respective owners.